Search research articles
Contact Us
Filters
Showing results (191-200 of 200) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 200 results.
The Journal of Infectious Diseases
|
April 1, 1988
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus
R M Hendry, J C Burns, E E Walsh, et al.
Vaccine
|
August 10, 2000
Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults
T G Boyce, H H Hsu, E C Sannella, et al.
Infection Control : IC
|
March 1, 1982
Nursery epidemic due to multiply-resistant Klebsiella pneumoniae: epidemiologic setting and impact on perinatal health care delivery
K T McKee, R B Cotton, C W Stratton, et al.
AIDS Research and Human Retroviruses
|
May 20, 1996
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group
M C Keefer, B S Graham, M J McElrath, et al.
The American Journal of Pathology
|
December 7, 2000
Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils
P N Boyaka, P F Wright, M Marinaro, et al.
The Journal of Infectious Diseases
|
September 9, 1999
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women
P F Wright, J S Lambert, G J Gorse, et al.
The Journal of Infectious Diseases
|
September 30, 2000
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
P F Wright, R A Karron, R B Belshe, et al.
The Journal of Infectious Diseases
|
February 18, 1998
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group
B S Graham, M J McElrath, R I Connor, et al.
The Journal of Infectious Diseases
|
May 21, 1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group
M L Clements-Mann, K Weinhold, T J Matthews, et al.
The New England Journal of Medicine
|
June 3, 2005
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
M N Oxman, M J Levin, G R Johnson, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 200) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 200 results.
The Journal of Infectious Diseases
|
April 1, 1988
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus
R M Hendry, J C Burns, E E Walsh, et al.
Vaccine
|
August 10, 2000
Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults
T G Boyce, H H Hsu, E C Sannella, et al.
Infection Control : IC
|
March 1, 1982
Nursery epidemic due to multiply-resistant Klebsiella pneumoniae: epidemiologic setting and impact on perinatal health care delivery
K T McKee, R B Cotton, C W Stratton, et al.
AIDS Research and Human Retroviruses
|
May 20, 1996
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group
M C Keefer, B S Graham, M J McElrath, et al.
The American Journal of Pathology
|
December 7, 2000
Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils
P N Boyaka, P F Wright, M Marinaro, et al.
The Journal of Infectious Diseases
|
September 9, 1999
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women
P F Wright, J S Lambert, G J Gorse, et al.
The Journal of Infectious Diseases
|
September 30, 2000
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
P F Wright, R A Karron, R B Belshe, et al.
The Journal of Infectious Diseases
|
February 18, 1998
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group
B S Graham, M J McElrath, R I Connor, et al.
The Journal of Infectious Diseases
|
May 21, 1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group
M L Clements-Mann, K Weinhold, T J Matthews, et al.
The New England Journal of Medicine
|
June 3, 2005
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
M N Oxman, M J Levin, G R Johnson, et al.
Page
of 20